Charles Schwab Investment Management Inc Standard Biotools Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Standard Biotools Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,332,649 shares of LAB stock, worth $2.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,332,649

Previous 2,445,083 4.6%

Holding current value

$2.71 Million

Previous $4.72 Million 13.5%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$1.5 - $2.26 $168,651 - $254,100	-112,434 Reduced 4.6%	2,332,649 $4.08 Million
Q3 2024 Nov 12, 2024	BUY	$1.42 - $2.35 $2.27 Million - $3.75 Million	1,597,728 Added 188.55%	2,445,083 $4.72 Million
Q2 2024 Aug 12, 2024	BUY	$1.65 - $2.92 $1.21 Million - $2.15 Million	735,771 Added 659.39%	847,355 $1.5 Million
Q1 2024 May 08, 2024	BUY	$1.87 - $2.78 $150,333 - $223,489	80,392 Added 257.73%	111,584 $302,000
Q1 2023 May 11, 2023	BUY	$1.3 - $2.24 $40,549 - $69,870	31,192 New	31,192 $60,000
Q2 2022 Aug 15, 2022	SELL	$1.6 - $3.99 $272,041 - $678,403	-170,026 Reduced 86.24%	27,127 $44,000
Q1 2022 May 13, 2022	BUY	$2.8 - $3.96 $15,926 - $22,524	5,688 Added 2.97%	197,153 $708,000
Q3 2021 Nov 16, 2021	BUY	$5.5 - $7.41 $29,491 - $39,732	5,362 Added 2.88%	191,465 $1.26 Million
Q2 2021 Aug 16, 2021	BUY	$4.35 - $6.35 $1,979 - $2,889	455 Added 0.25%	186,103 $1.15 Million
Q1 2021 May 17, 2021	BUY	$3.94 - $7.09 $16,808 - $30,245	4,266 Added 2.35%	185,648 $840,000
Q4 2020 Feb 16, 2021	BUY	$5.45 - $8.65 $79,853 - $126,739	14,652 Added 8.79%	181,382 $1.09 Million
Q3 2020 Nov 13, 2020	SELL	$4.34 - $11.43 $24,707 - $65,070	-5,693 Reduced 3.3%	166,730 $1.24 Million
Q2 2020 Aug 14, 2020	BUY	$1.85 - $5.29 $11,268 - $32,221	6,091 Added 3.66%	172,423 $692,000
Q1 2020 May 15, 2020	SELL	$1.24 - $4.35 $509 - $1,787	-411 Reduced 0.25%	166,332 $423,000
Q3 2019 Nov 08, 2019	BUY	$4.63 - $12.15 $11,362 - $29,816	2,454 Added 1.49%	166,743 $773,000
Q2 2019 Aug 09, 2019	BUY	$11.49 - $14.17 $897,414 - $1.11 Million	78,104 Added 90.62%	164,289 $2.03 Million
Q1 2019 May 14, 2019	BUY	$8.47 - $14.36 $109,822 - $186,191	12,966 Added 17.71%	86,185 $1.15 Million
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $96,348 - $118,489	13,419 Added 22.44%	73,219 $632,000
Q3 2018 Nov 13, 2018	BUY	$5.92 - $8.35 $30,192 - $42,585	5,100 Added 9.32%	59,800 $448,000
Q2 2018 Aug 08, 2018	SELL	$4.86 - $6.24 $83,106 - $106,704	-17,100 Reduced 23.82%	54,700 $327,000
Q4 2017 Jan 17, 2018	BUY	$4.46 - $6.45 $70,468 - $101,910	15,800 Added 28.21%	71,800 $423,000
Q3 2017 Nov 13, 2017	BUY	$3.55 - $5.49 $198,800 - $307,440	56,000	56,000 $283,000

Others Institutions Holding LAB

# of Institutions

143

Shares Held

274M

Call Options Held

6.7K

Put Options Held

48.7K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $91.2M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Standard Biotools Inc. Transaction History